Back to Results
First PageMeta Content
Pharmacology / National Institutes of Health / Nursing research / Pharmaceutical industry / Drug discovery / Spinal muscular atrophy / Clinical trial / Food and Drug Administration / Alternative medicine / Health / Medicine / Research


Microsoft Word - CTMC_CONTENT.doc
Add to Reading List

Document Date: 2014-02-10 11:19:57


Open Document

File Size: 121,13 KB

Share Result on Facebook

City

Springfield / /

Company

Aurora Bioscience/Vertex Pharmaceuticals / SAIC / Pfizer Inc. / Penwest Pharmaceuticals / Institute / Endo Pharmaceuticals / Edison 317 Pharmaceuticals / Repligen Corporation / Dainippon Sumitomo Pharmaceuticals / Electronic Data Systems / Vertex / /

Continent

America / /

Country

Japan / United States / /

Currency

USD / /

/

Event

Funding / Business Partnership / Labor Issues / FDA Phase / Person Communication and Meetings / M&A / /

Facility

NIH National Institute / Children's Hospital of Philadelphia / Rochester Institute of Technology / /

/

IndustryTerm

biopharmaceutical entities / biopharmaceutical and medical device industry players / insurance / large pharmaceutical / important translational tools / clinical network / pharmaceutical industry experience / industry advertising / disease / translational tools / biopharmaceutical development partners / foundation web / start-up / biopharmaceutical industry / on-line patient registry / biopharmaceutical / energy establishing / clinical networks / /

MedicalCondition

mitochondrial disorders / foundation's disease / C deficiency / Therapy Development JOINT-VENTURE PHILANTHROPY MUSCULAR ATROPHY / MELAS / Tourette syndrome / JOINT-VENTURE PHILANTHROPY DREICH ATAXIA / Far too few disease / diseases / inherited mitochondrial respiratory chain diseases / disorders / Friedreich Ataxia / Muscular Atrophy / Cystic Fibrosis / common diseases / Rett syndrome / ataxia / spinal muscular atrophy / disease / rare disease / Leber's hereditary optic neuropathy / Leigh syndrome / /

Organization

Rochester Institute of Technology / Ataxia Research Alliance / American Academy of Neurology / U.S. Congress / American Society of Experimental NeuroTherapeutics / NIH National Institute for Neurological Disorders and Stroke / Senate Finance Committee / FDA Center for Drug Evaluation / CDER's Division of Neurology Products / National Institute of Health / Children's Hospital of Philadelphia / Food and Drug Administration / Muscular Dystrophy Association / FDA Center for Drug Evaluation and Research / Congress / NIH Institute's National Advisory Council / NIH RAID / Cystic Fibrosis Foundation / Steering Committee / Friedreich's Ataxia Research Alliance / /

Person

Charles E. Grassley / David Lynch / Janet Woodcock / Russell Katz / Ronald J. Bartek Accepted / Ronald J. Bartek / Jill Jarecki / Friedreich / /

/

Position

advisor / academic investigator / ACKNOWLEDGEMENTS The author / player / author at Co-Founder/President / advocate / author / contractor / academic principle investigator / leading academic FRDA investigator / Director for Families / Research / try CEO / Co-Founder and President / academic scientist / investigator / program director / candidate in clinical development / scientist / Co-Founder /President / Senator / business model for medical therapy development has changed drastically / Director / Director for Families Research / /

Product

Kalydeco / SMA / Friedreich / FRDA / /

ProvinceOrState

Virginia / /

PublishedMedium

the Chronicle / the NDA review / /

Technology

Neuroscience / html / RAID / cell assays / pdf / drug development / /

URL

http /

SocialTag